ES2532481T3 - Agente anti-obesidad y alimento anti-obesidad - Google Patents

Agente anti-obesidad y alimento anti-obesidad Download PDF

Info

Publication number
ES2532481T3
ES2532481T3 ES12189236.8T ES12189236T ES2532481T3 ES 2532481 T3 ES2532481 T3 ES 2532481T3 ES 12189236 T ES12189236 T ES 12189236T ES 2532481 T3 ES2532481 T3 ES 2532481T3
Authority
ES
Spain
Prior art keywords
obesity
food
agent
obesity agent
obesity food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12189236.8T
Other languages
English (en)
Inventor
Hidetoshi Morita
Toshio Masaoka
Takehito Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Application granted granted Critical
Publication of ES2532481T3 publication Critical patent/ES2532481T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Lactobacillus rhamnosus ATCC53103 para su uso en la prevención o terapia de la obesidad.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
ES12189236.8T 2005-07-26 2006-07-25 Agente anti-obesidad y alimento anti-obesidad Active ES2532481T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005215895 2005-07-26
JP2005215895 2005-07-26

Publications (1)

Publication Number Publication Date
ES2532481T3 true ES2532481T3 (es) 2015-03-27

Family

ID=37683334

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12189236.8T Active ES2532481T3 (es) 2005-07-26 2006-07-25 Agente anti-obesidad y alimento anti-obesidad

Country Status (9)

Country Link
US (3) US20100216212A1 (es)
EP (2) EP1918373B1 (es)
JP (2) JP5144263B2 (es)
KR (3) KR101411144B1 (es)
CN (3) CN102225078B (es)
ES (1) ES2532481T3 (es)
PL (1) PL2604689T3 (es)
PT (1) PT2604689E (es)
WO (1) WO2007013438A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5679576B2 (ja) * 2011-06-06 2015-03-04 東芝エレベータ株式会社 乗客コンベア
KR101394348B1 (ko) * 2011-10-28 2014-05-13 대상에프앤에프 주식회사 대사질환 또는 염증질환 치료 및 예방 효과가 있는 락토바실러스 플란타륨 ｄｓｒ920 및 이의 용도
CN102583145A (zh) * 2012-01-19 2012-07-18 快速电梯有限公司 机械式踏板遗失检测装置及具有该检测装置的自动人行道
ES2711427T3 (es) * 2012-06-04 2019-05-03 Biogaia Ab Lactobacillus reuteri ATCC PTA 6475 para su uso en la prevención o el tratamiento de la pérdida ósea en mamíferos
BR112015010639A2 (pt) * 2012-11-12 2017-07-11 Biopolis SL lactobacillus rhamnosus para redução da acumulação de gordura corporal
JP2016501010A (ja) 2012-11-12 2016-01-18 コンパニ・ジェルベ・ダノンＣｏｍｐａｇｎｉｅ Ｇｅｒｖａｉｓ Ｄａｎｏｎｅ 体重増加及び／又はインスリン抵抗性を低減させるためのラクトバチルスラムノサス株の使用
WO2014171478A1 (ja) 2013-04-17 2014-10-23 サントリーホールディングス株式会社 ラクトバチルス属菌含有組成物
CN105143438B (zh) 2013-04-17 2017-10-31 三得利控股株式会社 乳杆菌属菌
WO2015065796A1 (en) 2013-10-31 2015-05-07 E. I. Du Pont De Nemours And Company Aqueous ink-jet inks containing two or more binders
KR102125548B1 (ko) * 2015-02-10 2020-06-24 주식회사 지니스 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물
CN115887508A (zh) 2016-03-04 2023-04-04 加利福尼亚大学董事会 微生物聚生体及其用途
JP6545386B2 (ja) * 2016-07-28 2019-07-17 三菱電機株式会社 乗客コンベアの走行異常検出装置および乗客コンベアの走行異常検出方法
US10653728B2 (en) 2016-10-17 2020-05-19 New York University Probiotic compositions for improving metabolism and immunity
JP6400812B1 (ja) * 2017-09-06 2018-10-03 東芝エレベータ株式会社 乗客コンベアの異常検出システム
WO2019168990A1 (en) * 2018-02-27 2019-09-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Probiotics and probiotic compositions for regulating body weight
EP3773645A4 (en) 2018-04-10 2021-11-24 Siolta Therapeutics, Inc. MICROBIAL CONSORTIA
EP3599212B1 (en) 2018-07-27 2024-06-12 Otis Elevator Company Drive misalignment monitoring in a people conveyor
JP7576901B2 (ja) * 2018-08-22 2024-11-01 ディーエスエム アイピー アセッツ ビー．ブイ． 食品及び栄養補助食品としてのスクロースイソメラーゼ
WO2020068936A1 (en) * 2018-09-25 2020-04-02 Duke University Methods and compositions to treat and prevent infection
KR102128287B1 (ko) 2019-08-23 2020-06-30 주식회사 엔테로바이옴 아커만시아 뮤시니필라 eb-amdk19 균주 및 그의 용도
KR102128289B1 (ko) 2019-08-23 2020-06-30 주식회사 엔테로바이옴 아커만시아 뮤시니필라 eb-amdk27 균주 및 그의 용도
CN120732903A (zh) 2019-10-07 2025-10-03 谢尔塔治疗公司 治疗性药物组合物
CN111254090B (zh) * 2019-12-30 2021-11-05 杭州娃哈哈科技有限公司 一株具有减肥功能的罗伊氏乳杆菌及其应用
JP7074253B1 (ja) * 2021-11-01 2022-05-24 三菱電機株式会社 乗客コンベアの異常検出装置
CN114344344B (zh) * 2022-01-05 2023-06-13 东北农业大学 罗伊氏乳杆菌在缓解高脂饮食诱导小鼠肥胖功能中的应用及含有罗伊氏乳杆菌的复合物
KR102732392B1 (ko) 2024-06-21 2024-11-26 주식회사 엔테로바이옴 아커만시아 속 균주를 포함하는 조성물
CN118685463B (zh) * 2024-07-25 2025-04-25 杭州微远生物科技有限公司 一种达泊西汀手性中间体的酶催化合成方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DE69834251T2 (de) * 1997-07-05 2007-01-04 Société des Produits Nestlé S.A. gefrorenes Dessert, welches Milchsäurebakterien und fermentierbare Ballaststoffe enthält
AU3843200A (en) 1999-04-27 2000-11-10 Kabushiki Kaisha Yakult Honsha Conjugated fatty acid esters
US6641808B1 (en) * 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
JP2001120288A (ja) * 1999-10-29 2001-05-08 Yakult Honsha Co Ltd 共役脂肪酸グリセリド含有脂質の製造法及び組成物
JP4580542B2 (ja) * 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
JP4157674B2 (ja) * 2000-08-14 2008-10-01 株式会社ヤクルト本社 共役脂肪酸含有発酵食品及びその製造法
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US20050100531A1 (en) 2002-06-13 2005-05-12 John Bienenstock Probiotic therapies
AU2003250503A1 (en) * 2002-06-13 2003-12-31 University College Cork - National University Of Ireland, Cork Probiotic therapies using lactobacillus reuteri
US6942857B2 (en) 2002-08-09 2005-09-13 Bioneer Corporation Microorganisms for preventing and/or treating obesity or diabetes mellitus
KR100794701B1 (ko) 2002-08-09 2008-01-14 (주)바이오니아 비만 또는 당뇨 예방 및 치료용 미생물
KR100794702B1 (ko) * 2003-07-21 2008-01-14 (주)바이오니아 비만증 또는 당뇨병 예방 및/또는 치료용 미생물
JP2003081855A (ja) * 2002-08-19 2003-03-19 Yakult Honsha Co Ltd 脂質代謝改善剤およびそれを含有する食品
KR20040027180A (ko) 2002-09-27 2004-04-01 (주)바이오니아 비만 또는 당뇨병의 예방 및 치료 효과를 갖는 유산균발효 유제품 및 그 제조방법
KR20040037011A (ko) * 2002-10-26 2004-05-04 (주)바이오니아 유산균 함유 식품조성물 및 그 제조방법
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
JP2005278414A (ja) * 2004-03-26 2005-10-13 Nippon Shokubai Co Ltd １，３−プロパンジオール及び３−ヒドロキシプロピオン酸を製造する方法
JP2005304362A (ja) * 2004-04-20 2005-11-04 Nippon Shokubai Co Ltd １，３−プロパンジオール及び／又は３−ヒドロキシプロピオン酸を製造する方法
JP2005314038A (ja) * 2004-04-28 2005-11-10 Hitachi Ltd 乗客コンベア
KR100740097B1 (ko) 2005-10-20 2007-07-16 삼성에스디아이 주식회사 배터리의 ｓｏｃ 추정 방법 및 이를 이용한 배터리 관리시스템
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
JP5077157B2 (ja) * 2008-08-04 2012-11-21 高梨乳業株式会社 機能性飲食品
FI123157B (fi) * 2009-05-12 2012-11-30 Valio Oy Probioottien uusi käyttö

Also Published As

Publication number Publication date
EP1918373A4 (en) 2009-02-25
KR20110095929A (ko) 2011-08-25
CN101370729B (zh) 2012-08-29
JP2011206057A (ja) 2011-10-20
US8637001B2 (en) 2014-01-28
US20100216212A1 (en) 2010-08-26
CN102225078A (zh) 2011-10-26
US8637000B2 (en) 2014-01-28
CN102225078B (zh) 2012-12-26
PT2604689E (pt) 2015-03-09
EP1918373A1 (en) 2008-05-07
CN101233231B (zh) 2011-06-29
EP2604689B1 (en) 2015-01-21
US20120027736A1 (en) 2012-02-02
CN101233231A (zh) 2008-07-30
PL2604689T3 (pl) 2015-08-31
US20110311501A1 (en) 2011-12-22
WO2007013438A1 (ja) 2007-02-01
KR20080034474A (ko) 2008-04-21
EP2604689A1 (en) 2013-06-19
JPWO2007013438A1 (ja) 2009-02-05
KR20140043145A (ko) 2014-04-08
KR101411144B1 (ko) 2014-06-26
EP1918373B1 (en) 2014-08-20
CN101370729A (zh) 2009-02-18
JP5144263B2 (ja) 2013-02-13

Similar Documents

Publication Publication Date Title
ES2532481T3 (es) Agente anti-obesidad y alimento anti-obesidad
ES2651627T3 (es) Lactobacillus rhamnosus y control de peso
ES2489741T3 (es) Composición para la prevención de la aparición de acontecimientos cardiovasculares
BRPI0417825A (pt) métodos para uso de lactobacilli probióticos para animais de estimação
EP1527159A4 (en) PROBIOTIC PROPIONIBACTERIUM JENSENII 702
IL178286A0 (en) Gossypol co-crystals and the use thereof
EP1974740A4 (en) USE OF TGF-BETA1 INHIBITORY PEPTIDES IN THE PREPARATION OF AN IMMUNE RESPONSE MODULATING AGENT
BRPI0812766A2 (pt) 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
EP1712183A4 (en) ULTRASONOGRAPHIC BIOLOGICAL MOTION DETECTION DEVICE, IMAGE PRESENTATION DEVICE USING THE SAME, AND TREATMENT DEVICE
AU312968S (en) Plate
BR0004860B1 (pt) dispositivo para o condicionamento e a distribuição de uma composição e uso do dispositivo.
ES2486844T3 (es) Sustancia que presenta propiedad antidepresiva
AU307386S (en) Grille
ITMI20031806A1 (it) Argille organofiliche e loro impiego nella preparazione di materiali nanocompositi.
ITRM20050478A1 (it) Apparato per l'applicazione contemporanea della carbossiterapia e della mesoterapia.
CL2004001006A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceuticas que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topic
RU2003120857A (ru) Адаптогенное средство
GB0521276D0 (en) Medical uses and therapies based upon the action of azurocidin on IGFBP-1
Brouillard Student and faculty perceptions of the causes and solutions to truancy
CL2004001008A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 3; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topicas
Wu et al. The inverse problem of linear equations Ax= b.
Perrings Human Well-Being and the Natural Environment
ITRM20010726A1 (it) Dispositivo idoneo ad alimentare sostanze in polvere o simili e relativo uso.
ES1055566Y (es) Piezas roscada para muebles y similares.